Bispecific Antibody
JPM 2026 Recap: Capital Markets Reopen, AI Moves to the Last Mile, Metabolic Stakes Climb
2026-01-15
Early 2026 Biotech Fundraising: Parabilis and EpiBiologics Secure Major Rounds to Advance Oncology Pipelines
2026-01-09
Sanofi Acquires Bispecific Drug Candidate in $600 Million Deal Focused on Autoimmune Disorders
2025-03-21
ASCO 2024: Covering Skin Cancer, Bispecific Antibody Treatment, TIGIT-Targeted Drugs, Radiotherapy and More
2024-05-29
Regeneron Pays CytomX $2 Billion Biobucks to Develop Bispecific Cancer Therapies Together
2022-11-17
Gilead and MacroGenics Strike Potential $1.7 billion Collaboration Over Bispecific Antibodies
2022-10-17
LATEST
Forced Migrants in Ukraine Face Barriers to HIV and TB Care Amid Disrupted Healthcare Systems
2026-01-23
Residual Cardiovascular Risk Persists in Coronary Artery Disease Despite Advances in Treatment
2026-01-23
Advocacy-Informed Research and PRISM Framework Highlighted in Healthcare Policy Reform Strategies
2026-01-23
Study Explores Link Between Red Blood Cell Distribution Width and Prognosis in Peripheral T-Cell Lymphoma
2026-01-23



